138 related articles for article (PubMed ID: 34826708)
21. Substituted N-benzylpyrazine-2-carboxamides: synthesis and biological evaluation.
Servusová B; Eibinová D; Doležal M; Kubíček V; Paterová P; Peško M; Kráľová K
Molecules; 2012 Nov; 17(11):13183-98. PubMed ID: 23132136
[TBL] [Abstract][Full Text] [Related]
22. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
[TBL] [Abstract][Full Text] [Related]
23. Substituted pyrazinecarboxamides: synthesis and biological evaluation.
Dolezal M; Palek L; Vinsova J; Buchta V; Jampilek J; Kralova K
Molecules; 2006 Mar; 11(4):242-56. PubMed ID: 17962755
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis and Evaluation of
Zitko J; Mindlová A; Valášek O; Jand'ourek O; Paterová P; Janoušek J; Konečná K; Doležal M
Molecules; 2018 Sep; 23(9):. PubMed ID: 30231544
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
Abhale YK; Shinde A; Shelke M; Nawale L; Sarkar D; Mhaske PC
Bioorg Chem; 2021 Oct; 115():105192. PubMed ID: 34314920
[TBL] [Abstract][Full Text] [Related]
26. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
[TBL] [Abstract][Full Text] [Related]
28. Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity.
Kucerova-Chlupacova M; Kunes J; Buchta V; Vejsova M; Opletalova V
Molecules; 2015 Jan; 20(1):1104-17. PubMed ID: 25587786
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 6-[4-(4-Propoxyphenyl)piperazin-1-yl]-9H-purine Derivatives as Antimycobacterial and Antifungal Agents: In Vitro Evaluation and In Silico Study.
Nadaf AQA; Najare MS; Garbhagudi M; Mantur S; Sunagar MG; Gaonkar S; Joshi S; Khazi IAM
Chem Biodivers; 2020 May; 17(5):e2000053. PubMed ID: 32170847
[TBL] [Abstract][Full Text] [Related]
30. Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.
Sharma K; Tanwar O; Sharma S; Ali S; Alam MM; Zaman MS; Akhter M
Bioorg Chem; 2018 Oct; 80():319-333. PubMed ID: 29986181
[TBL] [Abstract][Full Text] [Related]
31. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
34. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
35. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
[TBL] [Abstract][Full Text] [Related]
36. Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors.
Garzan A; Willby MJ; Ngo HX; Gajadeera CS; Green KD; Holbrook SY; Hou C; Posey JE; Tsodikov OV; Garneau-Tsodikova S
ACS Infect Dis; 2017 Apr; 3(4):302-309. PubMed ID: 28192916
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by bengamide derivatives.
Lu JP; Yuan XH; Yuan H; Wang WL; Wan B; Franzblau SG; Ye QZ
ChemMedChem; 2011 Jun; 6(6):1041-8. PubMed ID: 21465667
[TBL] [Abstract][Full Text] [Related]
38. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
39. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
40. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
